150 related articles for article (PubMed ID: 9258371)
1. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
[TBL] [Abstract][Full Text] [Related]
2. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
[TBL] [Abstract][Full Text] [Related]
4. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
[TBL] [Abstract][Full Text] [Related]
5. Chemical design of radiolabeled antibody fragments for low renal radioactivity levels.
Arano Y; Fujioka Y; Akizawa H; Ono M; Uehara T; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Saji H
Cancer Res; 1999 Jan; 59(1):128-34. PubMed ID: 9892197
[TBL] [Abstract][Full Text] [Related]
6. In vitro system to estimate renal brush border enzyme-mediated cleavage of Peptide linkages for designing radiolabeled antibody fragments of low renal radioactivity levels.
Fujioka Y; Satake S; Uehara T; Mukai T; Akizawa H; Ogawa K; Saji H; Endo K; Arano Y
Bioconjug Chem; 2005; 16(6):1610-6. PubMed ID: 16287261
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels.
Uehara T; Koike M; Nakata H; Hanaoka H; Iida Y; Hashimoto K; Akizawa H; Endo K; Arano Y
Bioconjug Chem; 2007; 18(1):190-8. PubMed ID: 17226973
[TBL] [Abstract][Full Text] [Related]
8. Renal metabolism of 3'-iodohippuryl N(epsilon)-maleoyl-L-lysine (HML)-conjugated Fab fragments.
Fujioka Y; Arano Y; Ono M; Uehara T; Ogawa K; Namba S; Saga T; Nakamoto Y; Mukai T; Konishi J; Saji H
Bioconjug Chem; 2001; 12(2):178-85. PubMed ID: 11312678
[TBL] [Abstract][Full Text] [Related]
9. Renal brush border enzyme-cleavable linkages for low renal radioactivity levels of radiolabeled antibody fragments.
Akizawa H; Imajima M; Hanaoka H; Uehara T; Satake S; Arano Y
Bioconjug Chem; 2013 Feb; 24(2):291-9. PubMed ID: 23330714
[TBL] [Abstract][Full Text] [Related]
10. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
[TBL] [Abstract][Full Text] [Related]
11. [Design of radiolabeled antibody fragments for tumor-selective radioactivity localization--brush border enzyme-sensitive bond to decrease renal accumulation of radioactivity].
Mukai T; Fujioka Y; Arano Y; Saji H
Yakugaku Zasshi; 2003 Aug; 123(8):647-52. PubMed ID: 12931660
[TBL] [Abstract][Full Text] [Related]
12. Renal metabolism of 111In-DTPA-D-Phe1-octreotide in vivo.
Akizawa H; Arano Y; Uezono T; Ono M; Fujioka Y; Uehara T; Yokoyama A; Akaji K; Kiso Y; Koizumi M; Saji H
Bioconjug Chem; 1998; 9(6):662-70. PubMed ID: 9815158
[TBL] [Abstract][Full Text] [Related]
13. (67/68)Ga-labeling agent that liberates (67/68)Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels.
Uehara T; Rokugawa T; Kinoshita M; Nemoto S; Fransisco Lazaro GG; Hanaoka H; Arano Y
Bioconjug Chem; 2014 Nov; 25(11):2038-45. PubMed ID: 25303645
[TBL] [Abstract][Full Text] [Related]
14. A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides.
Arano Y; Mukai T; Uezono T; Wakisaka K; Motonari H; Akizawa H; Taoka Y; Yokoyama A
J Nucl Med; 1994 May; 35(5):890-8. PubMed ID: 8176478
[TBL] [Abstract][Full Text] [Related]
15. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
16. Stability of a metabolizable ester bond in radioimmunoconjugates.
Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
[TBL] [Abstract][Full Text] [Related]
17. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the hepatic radioactivity levels of [
Suzuki H; Matsukawa M; Madokoro R; Terasaka Y; Kannaka K; Uehara T
Nucl Med Biol; 2024 Apr; 132-133():108910. PubMed ID: 38636351
[TBL] [Abstract][Full Text] [Related]
19. (99m)Tc-HYNIC-derivatized ternary ligand complexes for (99m)Tc-labeled polypeptides with low in vivo protein binding.
Ono M; Arano Y; Mukai T; Fujioka Y; Ogawa K; Uehara T; Saga T; Konishi J; Saji H
Nucl Med Biol; 2001 Apr; 28(3):215-24. PubMed ID: 11323230
[TBL] [Abstract][Full Text] [Related]
20. Species difference in radioactivity elimination from liver parenchymal cells after injection of radiolabeled proteins.
Mukai T; Arano Y; Nishida K; Sasaki H; Akizawa H; Ogawa K; Ono M; Saji H; Nakamura J
Nucl Med Biol; 1999 Apr; 26(3):281-9. PubMed ID: 10363799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
